-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The POD24 Challenge: Where Do We Go From Here in Follicular Lymphoma?

Program: Education Program
Session: Follicular Lymphoma: Playing the Long Game
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Carla Casulo, MD

James P. Wilmot Cancer Center, Rochester, NY

Disclosures: Casulo: Verastem: Research Funding; AbbVie: Consultancy, Honoraria; Genmab: Research Funding; Gilead Sciences, Secura Bio: Research Funding; Genentech: Consultancy, Honoraria, Research Funding; Bristol Myers Squibb: Consultancy, Honoraria, Research Funding.

See more of: Follicular Lymphoma: Playing the Long Game
See more of: Education Program
<< Previous Presentation | Next Presentation >>